RESEARCH-USE BIOSIMILAR ANTIBODY
Lanadelumab
Monoclonal antibody · IgG1
Lanadelumab (SHP643) is a human IgG1 monoclonal antibody against plasma kallikrein (pKal) with an Ki value of 0.12 nM. Lanadelumab inhibits both free and HMWK (high molecular weight kininogen)-bound pKal. Lanadelumab has the potential for the research of hereditary angioedema.
TARGETKLKB1
YMonoclonal antibody
CATALOGSC-BS-445
CATALOG NUMBERSC-BS-445
MOLECULAR WEIGHTApprox. 145.72 kDa
PRODUCT FORMATMonoclonal antibody
PRODUCT OVERVIEW
A research-use configuration for comparative antibody studies
Lanadelumab (SHP643) is a human IgG1 monoclonal antibody against plasma kallikrein (pKal) with an Ki value of 0.12 nM. Lanadelumab inhibits both free and HMWK (high molecular weight kininogen)-bound pKal. Lanadelumab has the potential for the research of hereditary angioedema.
Lanadelumab is a recombinant research-use antibody directed against KLKB1.